Related references
Note: Only part of the references are listed.Human papillomaviruses: diversity, infection and host interactions
Alison A. McBride
NATURE REVIEWS MICROBIOLOGY (2022)
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform
Ilaria Zanella et al.
JOURNAL OF EXTRACELLULAR VESICLES (2021)
Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case
Enrico Koenig et al.
FRONTIERS IN IMMUNOLOGY (2021)
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine
Carmela Irene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations
Sara Valentini et al.
VACCINE (2019)
Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses
Somayeh Pouyanfard et al.
JOURNAL OF VIROLOGY (2018)
Some Gram-negative Lipoproteins Keep Their Surface Topology When Transplanted from One Species to Another and Deliver Foreign Polypeptides to the Bacterial Surface
Laura Fantappie et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles
Gloria Spagnoli et al.
SCIENTIFIC REPORTS (2017)
Bioengineering bacterial outer membrane vesicles as vaccine platform
Matthias J. H. Gerritzen et al.
BIOTECHNOLOGY ADVANCES (2017)
Enter B and W: two new meningococcal vaccine programmes launched
Shamez N. Ladhani et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
Omar Rossi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria
Yogesh Hooda et al.
NATURE MICROBIOLOGY (2016)
Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 Vaccine
Hanna Seitz et al.
CANCER PREVENTION RESEARCH (2015)
A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens
Monica Konar et al.
PLOS ONE (2015)
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
Christiane Gerke et al.
PLOS ONE (2015)
A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses
Hanna Seitz et al.
VACCINE (2014)
A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope
Elena Canali et al.
SCIENTIFIC REPORTS (2014)
Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas
Pamela L. Beatty et al.
RENAISSANCE OF CANCER IMMUNOTHERAPY (2013)
MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
Takashi Kimura et al.
CANCER PREVENTION RESEARCH (2013)
Influence of Oxidation and Multimerization on the Immunogenicity of a Thioredoxin-L2 Prophylactic Papillomavirus Vaccine
Hanna Seitz et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
MUC1 immunotherapy is here to stay
Takashi Kimura et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
High Yield Production Process for Shigella Outer Membrane Particles
Francesco Berlanda Scorza et al.
PLOS ONE (2012)
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
Davide Serruto et al.
VACCINE (2012)
Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States-National Health and Nutrition Examination Survey, 2003-2006: Opportunity to Measure HPV Vaccine Impact?
Eileen F. Dunne et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
Ivonne Rubio et al.
VIROLOGY (2011)
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
Adam Kulp et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
Terri N. Ellis et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2010)
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
David J. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Hans-Ulrich Bernard et al.
VIROLOGY (2010)
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
B. Romanowski et al.
LANCET (2009)
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20-38) peptide displayed on bacterial thioredoxin
Ivonne Rubio et al.
VACCINE (2009)
Papillomaviruses in the causation of human cancers - a brief historical account
Harald zur Hausen
VIROLOGY (2009)
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2008)
Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles
NC Kesty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Against which human papillomavirus types shall we vaccinate and screen?: The international perspective
N Muñoz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students
RL Winer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
